Literature DB >> 30279173

Remodeling of the Collagen Matrix in Aging Skin Promotes Melanoma Metastasis and Affects Immune Cell Motility.

Amanpreet Kaur1,2,3, Brett L Ecker2, Stephen M Douglass2, Curtis H Kugel2, Marie R Webster2, Filipe V Almeida2, Rajasekharan Somasundaram2, James Hayden2, Ehsan Ban3, Hossein Ahmadzadeh3, Janusz Franco-Barraza4, Neelima Shah4, Ian A Mellis3, Frederick Keeney2, Andrew Kossenkov2, Hsin-Yao Tang2, Xiangfan Yin2, Qin Liu2, Xiaowei Xu5, Mitchell Fane2, Patricia Brafford2, Meenhard Herlyn2, David W Speicher2, Jennifer A Wargo6, Michael T Tetzlaff6, Lauren E Haydu6, Arjun Raj3, Vivek Shenoy3, Edna Cukierman4, Ashani T Weeraratna7.   

Abstract

Physical changes in skin are among the most visible signs of aging. We found that young dermal fibroblasts secrete high levels of extracellular matrix (ECM) constituents, including proteoglycans, glycoproteins, and cartilage-linking proteins. The most abundantly secreted was HAPLN1, a hyaluronic and proteoglycan link protein. HAPLN1 was lost in aged fibroblasts, resulting in a more aligned ECM that promoted metastasis of melanoma cells. Reconstituting HAPLN1 inhibited metastasis in an aged microenvironment, in 3-D skin reconstruction models, and in vivo. Intriguingly, aged fibroblast-derived matrices had the opposite effect on the migration of T cells, inhibiting their motility. HAPLN1 treatment of aged fibroblasts restored motility of mononuclear immune cells, while impeding that of polymorphonuclear immune cells, which in turn affected regulatory T-cell recruitment. These data suggest that although age-related physical changes in the ECM can promote tumor cell motility, they may adversely affect the motility of some immune cells, resulting in an overall change in the immune microenvironment. Understanding the physical changes in aging skin may provide avenues for more effective therapy for older patients with melanoma. SIGNIFICANCE: These data shed light on the mechanochemical interactions that occur between aged skin, tumor, and immune cell populations, which may affect tumor metastasis and immune cell infiltration, with implications for the efficacy of current therapies for melanoma.See related commentary by Marie and Merlino, p. 19.This article is highlighted in the In This Issue feature, p. 1. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30279173      PMCID: PMC6328333          DOI: 10.1158/2159-8290.CD-18-0193

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   39.397


  93 in total

1.  Something Old, Something New: The Tumor Microenvironment Comes of Age.

Authors:  Kerrie L Marie; Glenn Merlino
Journal:  Cancer Discov       Date:  2019-01       Impact factor: 39.397

2.  Meeting report: Metastasis Research Society (MRS) 17th Biennial conference and associated Young Investigator Satellite Meeting (YISM) on cancer metastasis.

Authors:  Thomas Beadnell; Lucia Borriello; Jessica Christenson; Jaime Fornetti; Ian Guldner; Ann Hanna; Lenka Kyjacova; Kristina Marinak-Whately; Poliana Cristina de Melo Martins; Mirja Rotinen; Veronika Te Boekhorst; Thomas R Cox
Journal:  Clin Exp Metastasis       Date:  2019-01-23       Impact factor: 5.150

3.  A Role for HAPLN1 During Phenotypic Modulation of Human Lung Fibroblasts In Vitro.

Authors:  Stephen P Evanko; Michel D Gooden; Inkyung Kang; Christina K Chan; Robert B Vernon; Thomas N Wight
Journal:  J Histochem Cytochem       Date:  2020-10-16       Impact factor: 2.479

Review 4.  Molecular principles of metastasis: a hallmark of cancer revisited.

Authors:  Jawad Fares; Mohamad Y Fares; Hussein H Khachfe; Hamza A Salhab; Youssef Fares
Journal:  Signal Transduct Target Ther       Date:  2020-03-12

Review 5.  Cryptic collagen elements as signaling hubs in the regulation of tumor growth and metastasis.

Authors:  XiangHua Han; Jennifer M Caron; Peter C Brooks
Journal:  J Cell Physiol       Date:  2020-05-12       Impact factor: 6.384

6.  Identification of a novel therapeutic candidate, NRK, in primary cancer-associated fibroblasts of lung adenocarcinoma microenvironment.

Authors:  Tongtong Wei; Jinjing Song; Kai Liang; Li Li; Xiaoxiang Mo; Zhiguang Huang; Gang Chen; Naiquan Mao; Jie Yang
Journal:  J Cancer Res Clin Oncol       Date:  2021-01-02       Impact factor: 4.553

Review 7.  The matrix in cancer.

Authors:  Thomas R Cox
Journal:  Nat Rev Cancer       Date:  2021-02-15       Impact factor: 60.716

Review 8.  Defining the Hallmarks of Metastasis.

Authors:  Danny R Welch; Douglas R Hurst
Journal:  Cancer Res       Date:  2019-05-03       Impact factor: 12.701

9.  sFRP2 Supersedes VEGF as an Age-related Driver of Angiogenesis in Melanoma, Affecting Response to Anti-VEGF Therapy in Older Patients.

Authors:  Mitchell E Fane; Brett L Ecker; Amanpreet Kaur; Gloria E Marino; Gretchen M Alicea; Stephen M Douglass; Yash Chhabra; Marie R Webster; Andrea Marshall; Richard Colling; Olivia Espinosa; Nicholas Coupe; Neera Maroo; Leticia Campo; Mark R Middleton; Pippa Corrie; Xiaowei Xu; Giorgos C Karakousis; Ashani T Weeraratna
Journal:  Clin Cancer Res       Date:  2020-11-01       Impact factor: 12.531

10.  Engineering clinically-relevant human fibroblastic cell-derived extracellular matrices.

Authors:  Janusz Franco-Barraza; Kristopher S Raghavan; Tiffany Luong; Edna Cukierman
Journal:  Methods Cell Biol       Date:  2020-01-21       Impact factor: 1.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.